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The novel coronavirus (COVID-19) pandemic and
accompanying disease-mitigation measures have had an
unprecedented global impact. As of the time of writing, the
WHO identifies over 10.1 million global cases (2.5 million
US) and more than 500,000 fatalities (126,000 US) (World
Health Organization 2020a, b; Centers for Disease Control
2020).
The WHO defines disability as ‘‘any condition of the
body or mind that makes it more difficult for the person
with the condition to do certain activities and interact with
the world around them’’ (World Health Organization
2020a, b). Even prior to the COVID-19 pandemic, persons
with disabilities (PWD) were at greater risk for difficulties
accessing healthcare, performing instrumental activities of
daily living, and maintaining financial well-being (Kweon
2020; Lenze et al. 2001; Garberoglio et al. 2016; Gopinath
et al. 2012; World Health Organization 2001, 2011). The
impact of the COVID-19 on PWD has not been well
described, and it is not known whether the pandemic is
disproportionally creating challenges for PWD. Mitigation
measures currently in place across the globe are likely to
exacerbate many psychological, financial, and day-to-day
challenges (Gershman 2020).
Recently, scientific publications and advocacy groups
have provided broad recommendations to limit the impact
of the pandemic on PWD (Allen and Smith 2020; Senjam
2020; Kessler Foundation 2020; National Association of
the Deaf 2020; Rogers 2020). However, there are little data
to quantify the impact of the pandemic on PWD, and a
thorough review of existing survey instruments demon-
strated a clear gap in available instruments to assess the
impact on PWD. While long-standing rigorously validated
survey instruments like the WHO Model Disability Survey
are commonly used in disability survey research, existing
instruments may lack content validity since they were not
developed with this unprecedented global stressor in mind
(World Health Organization 2020a, b). We also reviewed
all COVID-19 surveys cataloged on the PhenX Toolkit
website (Hamilton et al. 2011); however, there was no
single instrument that appeared well targeted to PWD.
Accordingly, the decision was made to undertake the
development of a novel survey instrument to conduct
research specific to the impact of COVID-19 on PWD.
Given the highly specific nature of this construct, we
believe that this new instrument was needed in order to
optimize key measurement properties like content and
construct validity (Terwee et al. 2007).
We therefore developed a novel survey instrument, the
Coronavirus Disability Survey (COV-DIS), for the purpose
of assessing the impact of the COVID-19 pandemic and
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related disease-mitigation measures on PWD. The survey
includes items to assess general and psychological health,
instrumental activities of daily living, social isolation,
financial strain, and information and transportation access.
The 34-item COV-DIS was developed by consensus of a
group of experts from the fields of survey research, phys-
ical medicine and rehabilitation, family medicine, oph-
thalmology, and industrial and operations engineering. All
experts on the panel had extensive expertise in disability
research and/or the clinical care of PWD. The panel drafted
and iteratively refined relevant novel survey items. Addi-
tionally, based on the review of existing instruments, sev-
eral items were drawn from other surveys. Items were
included from the: CDC COVID-19 Community Survey,
Osteoporotic Fractures in Men Study (MROS) and Study of
Muscle Mobility and Aging (SOMMA) (Ware and Sher-
bourne 1992), Understanding America Study (Orwoll et al.
2005), 36-item Short-Form Survey (SF-36) (Hays et al.
1993), and Patient Health Questionnaire-2 (PHQ-2)
(Kroenke et al. 2003). Responses to these items can
therefore be easily harmonized with data from their parent
studies in order to make comparisons between populations.
For example, studies from which several of the COV-DIS
items were drawn make data publicly available. Data may
be directly compared between a study conducted with the
COV-DIS and publicly available data (e.g., a national
sample in the Understanding America Study). Items from
validated instruments such as the SF-36 and the PHQ-2 can
also be compared to data from national samples collected
in large epidemiological studies (e.g., the Health and
Retirement Study or the National Health and Aging Trends
Study).
Various COV-DIS items allow for the input of free text
to describe the unique experience of respondents. Ques-
tions ask respondents to compare current experiences to
their experiences prior to becoming aware of the pandemic.
This approach may be relevant to the current phase of the
pandemic. However, the nature of the pandemic and miti-
gation measures is likely to change in unpredictable ways.
Therefore, it is likely that there will be a need for future
users of the COV-DIS to modify question stems in order to
specify a timeframe of interest.
We are presently utilizing the COV-DIS to carry out
research on the impact of COVID-19 on PWD in southeast
Michigan, USA, an area strongly affected by the pandemic
(The New York Times 2020). Data will be analyzed to
determine the psychometric properties of the COV-DIS and
to obtain critical insights into how the COVID-19 pan-
demic and disease-mitigation measures are affecting the
health and well-being of PWD in this region.
The COV-DIS represents a novel instrument to facilitate
an urgent research need. However, there are several limi-
tations. Since results of the initial administration of the
COV-DIS are not yet available, the measurement proper-
ties of the survey are not known. Additionally, qualitative
research was not performed among PWD in order to inform
instrument development. Nonetheless, these limitations are
due to what we believe was the need to rapidly develop and
disseminate a highly relevant survey instrument to enable
meaningful research that may benefit the lives of PWD
during the COVID-19 pandemic.
In developing and making the COV-DIS freely and
publicly available (https://osf.io/p2w9j/.), we hope to pro-
mote opportunities for harmonization of data across diverse
study populations. Studies using the COV-DIS may have a
large impact by providing needed insights to shape data-
driven public health and policy decisions that have the
potential to optimize the health and well-being of PWD
now, during possible future waves of COVID-19 infection,
and during other future high-impact societal stressors.
Acknowledgements None.
Author contributions JRE contributed to the concept of the study.
JRE, AB, SW, JS, SU, CD, AS, KP, AR, PE, MM, and MMM con-
tributed to the design of the study. AB and JRE contributed to drafting
of the manuscript. All authors contributed to the review and editing of
the manuscript.
Funding Funding was provided by an unrestricted grant from the
Lighthouse Guild to the University of Michigan Department of
Ophthalmology and Visual Sciences. JRE is supported by a grant
from the National Institutes of Health (K23EY027848). This work
was supported by a grant to AB from the Michigan Institute for
Clinical and Health Research with funding provided by the National
Institutes of Health (TL1TR002242).
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical approval All procedures that will be performed in studies
involving human participants will be in accordance with the ethical
standards of the institutional committee (University of Michigan
Institutional Review Board (IRBMED), HUM00179203) and with the
1964 Declaration of Helsinki and its later amendments or comparable
ethical standards.
Informed consent Informed consent will be obtained from all indi-
vidual participants to be included in the survey. This study currently
includes no human subjects.
References
Allen PM, Smith L (2020) SARS-CoV-2 self-isolation: recommen-
dations for people with a vision impairment. Eye 34:1183–1184.
https://doi.org/10.1038/s41433-020-0917-x
Centers for Disease Control (2020) Cases in the U.S. https://www.
cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html.
Accessed 30 June 2020
123
A. Bernard et al.
Garberoglio CL, Cawthon S, Bond M (2016) Deaf people and
employment in the United States. Washington, DC: US Depart-
ment of Education, Office of Special Education Programs,
National Deaf Center on Postsecondary Outcomes
Gershman J (2020) A Guide to State Coronavirus Reopenings and
Lockdowns. The Wall Street Journal, Dow Jones & Company
www.wsj.com/articles/a-state-by-state-guide-to-coronavirus-
lockdowns-11584749351. Accessed 8 May 2020
Gopinath B, Schneider J, McMahon CM, Teber E, Leeder SR,
Mitchell P (2012) Severity of age-related hearing loss is
associated with impaired activities of daily living. Age Ageing
41(2):195–200
Hamilton et al (2011) The PhenX toolkit: get the most from your
measures. Am J Epidemiol 174(3):253–260
Hays RD, Sherbourne CD, Mazel RM (1993) The rand 36-item health
survey 1.0. Health Econ 2(3):217–227
Kessler Foundation (2020) COVID-19 and spinal cord injury:
minimizing risks for complications. https://kesslerfoundation.
org/info/covid-19-and-spinal-cord-injury-minimizing-risks-com
plications. Accessed 30 June 2020
Kroenke K, Spitzer RL, Williams JBW (2003) The patient health
questionnaire-2: validity of a two-item depression screener. Med
Care 41:1284–1292. https://doi.org/10.1097/01.MLR.
0000093487.78664.3C
Kweon S (2020) Pandemics hit people with disabilities hard. https://
www.iapb.org/news/pandemics-hit-people-with-disabilities-
hard/. Accessed 30 June 2020
Lenze EJ, Rogers JC, Martire LM, Mulsant BH, Rollman BL, Dew
MA, Reynolds CF III (2001) The association of late-life
depression and anxiety with physical disability: a review of the
literature and prospectus for future research. Am J Geriatr
Psychiatry 9(2):113–135
National Association of the Deaf (2020) COVID-19: deaf and hard of
hearing communication access recommendations for the hospi-
tal. https://www.nad.org/covid19-communication-access-recs-
for-hospital/. Accessed 30 June 2020
Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S,
Ensrud K, McGowan J (2005) Design and baseline character-
istics of the osteoporotic fractures in men (MrOS) study—a large
observational study of the determinants of fracture in older men.
Contemp Clin Trials 26(5):569–585
Rogers L (2020) COVID-19 and blindness: staying safe and how to
help. https://www.wsblind.org/blog/2020/3/26/covid-19-and-
blindness-staying-safe-and-how-to-help. Accessed 30 June 2020
Senjam SS (2020) Impact of COVID-19 pandemic on people living
with visual disability. Indian J Ophthalmol 68(7):1367
Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL,
Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were
proposed for measurement properties of health status question-
naires. J Clin Epidemiol 60(1):34–42
The New York Times (2020) Michigan coronavirus map and case
count. https://www.nytimes.com/interactive/2020/us/michigan-
coronavirus-cases.html. Accessed 30 June 2020
Ware J, Sherbourne C (1992) The MOS 36-item short-form health
survey (SF-36): I. Conceptual framework and item selection.
Med Care 30(6):473–483
World Health Organization (2001) International classification of
functioning, disability and health: ICF. https://apps.who.int/iris/
handle/10665/42407. Accessed 30 June 2020
World Health Organization (2011) World report on disability. Ac-
cessed 30 June 2020
World Health Organization (2020a) Model disability survey. In:
World Health Organization. https://www.who.int/disabilities/
data/mds/en/. Accessed 30 June 2020
World Health Organization (2020b) Coronavirus. https://www.who.
int/emergencies/diseases/novel-coronavirus-2019. Accessed 30
June 2020
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
123
Assessing the impact of COVID-19 on persons with disabilities: development of a novel survey
